Melanoma Therapy and Skin Sensitivity: Protecting Your Skin During Treatment

For patients navigating a melanoma diagnosis, the sun is often viewed through a lens of caution. However, as therapeutic landscapes evolve, the relationship between a patient’s skin and the environment becomes even more complex. While advanced treatments like immunotherapy and targeted therapies have revolutionized outcomes, they also bring unique side effects that require a vigilant eye.

Dr. Michael K. Wong, Physician-in-Chief at Roswell Park Comprehensive Cancer Center and a member of the CURE advisory board, emphasized in a recent interview that skin reactions are among the most common side effects for those on immunotherapy. To understand why, one must look at the skin’s biological role.

“Our skin is loaded with immune cells because it acts as a barrier against the outside world,” Wong explains. “When you give someone immunotherapy and activate the immune system, the skin can be one of the most reactive organs in the body.”

The "itchy dot" phenomenon

Immunotherapy works by revving up the body’s immune system to attack cancer cells. However, this heightened state of inflammation can cause the immune system to misidentify the skin as a target. This typically manifests as a "maculopapular" rash.

Wong described these as small, red, raised dots on the skin. “They are invariably itchy,” he noted, adding that the underlying inflammation makes the skin hypersensitive to various stimuli — most notably, sunlight.

Beyond the Standard Sunburn

While most people recognize a standard sunburn as a uniform redness and heat, patients on immunotherapy may experience "treatment-induced photosensitivity." Because the skin is already in a state of high alert, UV radiation can trigger a much more aggressive inflammatory response than a patient might have experienced prior to treatment.

Wong shared a vivid example of a patient who was a lifelong avid gardener. While on immunotherapy, she developed a series of discrete, mysterious spots on her skin. It was eventually discovered that these were simple bug bites.

“She hadn't really reacted very much to them in her entire lifetime of gardening,” Wong said. “But when you’re on immunotherapy, your skin sensitivity to stimuli goes up — both to noxious stimuli like bug bites and to sunlight.”

Red Flags and "Red Drugs"

While immunotherapy is the primary driver of skin sensitivity in melanoma care, Wong issued a "public service announcement" regarding other treatments. Though rarely used for melanoma, certain chemotherapies like doxorubicin can cause severe chemical reactions when the skin is exposed to light.

“Doxorubicin is the IV drug that looks red,” Wong said. “I tell people: if it’s a red drug, you have to be very careful, because that chemotherapy can have a direct chemical reaction to sunlight.”

For a patient, the takeaway is clear: your skin is no longer reacting to the world in the way it used to.

Protective Strategies

To manage this heightened sensitivity, Wong advised against any prolonged exposure of "naked skin" to UV radiation. Patients should look for specific red flags, including:

• Rashes that appear as clusters of small, itchy dots.
• Exaggerated reactions to minor irritants (like insects).
• Sunburns that occur much faster or feel more painful than usual.

By understanding that treatment puts the skin in a state of "high alert," patients can better protect themselves while continuing their journey toward healing.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.